Entries by Russell Radefeld

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

SAN FRANCISCO, Mar. 8, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Oppenheimer 28th Annual Healthcare Conference on March 20-21, 2018 in New York City. Denise Bevers, Co-Founder and Chief Operating Officer, will present and be available for one-on-one […]

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

San Francisco, CA (March 1, 2018) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the fourth quarter and full year ended December 31, 2017 and provided updates on its programs. “We continue to look forward to the upcoming approval of our […]

Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

SAN FRANCISCO, Feb. 13, 2018 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will participate in the Bank of America Merrill Lynch Animal Health Summit on February 26, 2018 in New York City. Richard Chin, M.D., President and Chief Executive Officer, will participate in […]

KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™

San Francisco, CA (December 21, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the European Marketing Authorization application for Mirataz™ (mirtazapine transdermal gel) has been submitted to the European Medicines Agency (EMA). The EMA has accepted the submission for review, with the […]

KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses

San Francisco, CA (December 4, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive topline results from its pivotal field effectiveness study of Zimeta™ (dipyrone oral gel) for the control of pyrexia (fever) in horses. This study was a multicenter, randomized, blinded, placebo-controlled […]